Zhong-Yin Zhang

Zhong-Yin Zhang

Purdue University

H-index: 95

North America-United States

About Zhong-Yin Zhang

Zhong-Yin Zhang, With an exceptional h-index of 95 and a recent h-index of 40 (since 2020), a distinguished researcher at Purdue University, specializes in the field of Protein tyrosine phosphatases, cell signaling, chemical biology & drug discovery.

His recent articles reflect a diverse array of research interests and contributions to the field:

Natural product-inspired molecules for covalent inhibition of SHP2 tyrosine phosphatase

Discovery of a selective TC-PTP degrader for cancer immunotherapy

Discovery of a SHP2 Degrader with In Vivo Anti-Tumor Activity

PRL2 phosphatase enhances oncogenic FLT3 signaling via dephosphorylation of the E3 ubiquitin ligase CBL at tyrosine 371

A small molecule inhibitor of PTP1B and PTPN2 enhances T cell anti-tumor immunity

Driving axon regeneration by orchestrating neuronal and non-neuronal innate immune responses via the IFNγ-cGAS-STING axis

Small Molecule Degraders of Protein Tyrosine Phosphatase 1B and T‐Cell Protein Tyrosine Phosphatase for Cancer Immunotherapy

Inhibition of PRMT5 by market drugs as a novel cancer therapeutic avenue

Zhong-Yin Zhang Information

University

Purdue University

Position

___

Citations(all)

27237

Citations(since 2020)

6647

Cited By

22925

hIndex(all)

95

hIndex(since 2020)

40

i10Index(all)

263

i10Index(since 2020)

161

Email

University Profile Page

Purdue University

Zhong-Yin Zhang Skills & Research Interests

Protein tyrosine phosphatases

cell signaling

chemical biology & drug discovery

Top articles of Zhong-Yin Zhang

Title

Journal

Author(s)

Publication Date

Natural product-inspired molecules for covalent inhibition of SHP2 tyrosine phosphatase

Tetrahedron

Weida Liang

Aaron D Krabill

Katelyn S Gallagher

Christine Muli

Zihan Qu

...

2024/3/2

Discovery of a selective TC-PTP degrader for cancer immunotherapy

Chemical Science

Zhang ZY Miao J

Dong J

Miao Y

Bai Y

Qu Z

...

2023/10/24

Discovery of a SHP2 Degrader with In Vivo Anti-Tumor Activity

Molecules

Zhang ZY Miao J

Bai Y

Miao Y

Qu Z

Dong J

...

2023/10

PRL2 phosphatase enhances oncogenic FLT3 signaling via dephosphorylation of the E3 ubiquitin ligase CBL at tyrosine 371

Blood

H Chen

Bai

Y.

et al.

2023/1/19

A small molecule inhibitor of PTP1B and PTPN2 enhances T cell anti-tumor immunity

Nature Communications

Shuwei Liang

Eric Tran

Xin Du

Jiajun Dong

Harrison Sudholz

...

2023/7/27

Driving axon regeneration by orchestrating neuronal and non-neuronal innate immune responses via the IFNγ-cGAS-STING axis

Neuron

Xu Wang

Chao Yang

Xuejie Wang

Jinmin Miao

Weitao Chen

...

2023/1/18

Small Molecule Degraders of Protein Tyrosine Phosphatase 1B and T‐Cell Protein Tyrosine Phosphatase for Cancer Immunotherapy

Angewandte Chemie International Edition

Jiajun Dong

Jinmin Miao

Yiming Miao

Zihan Qu

Sheng Zhang

...

2023/5/22

Inhibition of PRMT5 by market drugs as a novel cancer therapeutic avenue

Genes & Diseases

Lakshmi Prabhu

Matthew Martin

Lan Chen

Özlem Demir

Jiamin Jin

...

2023/1/1

PTP4A2 promotes lysophagy by dephosphorylation of VCP/p97 at Tyr805

Autophagy

Yunpeng Bai

Guimei Yu

Hong-Ming Zhou

Ovini Amarasinghe

Yuan Zhou

...

2023/5/4

Sesquiterpenoid analogs

2023/11/14

Lymphoid-specific tyrosine phosphatase (LYP) inhibitors

2023/4/18

Structure-based design of active-site-directed, highly potent, selective, and orally bioavailable low-molecular-weight protein tyrosine phosphatase inhibitors

Journal of medicinal chemistry

Rongjun He

Jifeng Wang

Zhi-Hong Yu

Julie S Moyers

M Dodson Michael

...

2022/10/5

PTPN22: Structure, function, and developments in inhibitor discovery with applications for immunotherapy

Brenson A Jassim

Jianping Lin

Zhong-Yin Zhang

2022/8/3

The Toxoplasma glucan phosphatase TgLaforin utilizes a distinct functional mechanism that can be exploited by therapeutic inhibitors

Journal of Biological Chemistry

Robert D Murphy

Tiantian Chen

Jianping Lin

Rongjun He

Li Wu

...

2022/7/1

Purification and cryo-EM structure determination of VCP/p97 dodecamers from mammalian and bacterial cells

STAR protocols

Guimei Yu

Yunpeng Bai

Zhong-Yin Zhang

2022/6/17

Targeted Covalent Inhibition of Small CTD Phosphatase-1 to Promote the Degradation of REST Transcription Factor in Human Cells

J med chem

B. P Medellin

2022

High-throughput screening strategies for space-based radiation countermeasure discovery

Karson S Putt

Yuhong Du

Haian Fu

Zhong-Yin Zhang

2022/11/1

The Q61H mutation decouples KRAS from upstream regulation and renders cancer cells resistant to SHP2 inhibitors

Nature communications

Teklab Gebregiworgis

Yoshihito Kano

Jonathan St-Germain

Nikolina Radulovich

Molly L Udaskin

...

2021/11/1

Cryo-electron microscopy structures of VCP/p97 reveal a new mechanism of oligomerization regulation

iScience

2021 G Yu

Y Bai

K Li

O Amarasinghe

W Jiang

...

2021/11/19

Systemic inhibition of PTPN22 augments anticancer immunity

The Journal of Clinical Investigation

Won Jin Ho

Sarah Croessmann

Jianping Lin

Zaw H Phyo

Soren Charmsaz

...

2021/9/1

See List of Professors in Zhong-Yin Zhang University(Purdue University)

Zhong-Yin Zhang FAQs

What is Zhong-Yin Zhang's h-index at Purdue University?

The h-index of Zhong-Yin Zhang has been 40 since 2020 and 95 in total.

What are Zhong-Yin Zhang's top articles?

The articles with the titles of

Natural product-inspired molecules for covalent inhibition of SHP2 tyrosine phosphatase

Discovery of a selective TC-PTP degrader for cancer immunotherapy

Discovery of a SHP2 Degrader with In Vivo Anti-Tumor Activity

PRL2 phosphatase enhances oncogenic FLT3 signaling via dephosphorylation of the E3 ubiquitin ligase CBL at tyrosine 371

A small molecule inhibitor of PTP1B and PTPN2 enhances T cell anti-tumor immunity

Driving axon regeneration by orchestrating neuronal and non-neuronal innate immune responses via the IFNγ-cGAS-STING axis

Small Molecule Degraders of Protein Tyrosine Phosphatase 1B and T‐Cell Protein Tyrosine Phosphatase for Cancer Immunotherapy

Inhibition of PRMT5 by market drugs as a novel cancer therapeutic avenue

...

are the top articles of Zhong-Yin Zhang at Purdue University.

What are Zhong-Yin Zhang's research interests?

The research interests of Zhong-Yin Zhang are: Protein tyrosine phosphatases, cell signaling, chemical biology & drug discovery

What is Zhong-Yin Zhang's total number of citations?

Zhong-Yin Zhang has 27,237 citations in total.

What are the co-authors of Zhong-Yin Zhang?

The co-authors of Zhong-Yin Zhang are Gen-Sheng Feng, Michael Cowley, Tony Tiganis, Alvan Hengge, Mark A Saper, Ph.D..

Co-Authors

H-index: 74
Gen-Sheng Feng

Gen-Sheng Feng

University of California, San Diego

H-index: 60
Michael Cowley

Michael Cowley

Monash University

H-index: 53
Tony Tiganis

Tony Tiganis

Monash University

H-index: 45
Alvan Hengge

Alvan Hengge

Utah State University

H-index: 33
Mark A Saper, Ph.D.

Mark A Saper, Ph.D.

University of Michigan

academic-engine